AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18274206
Drug: Combined levothyroxine
RxNorm normalized name: combinations of levothyroxine and liothyronine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined levothyroxine (50 microg) and liothyronine (12.5 microg) supplement
Trial: 9539578
Drug: Interstitial thermometry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interstitial thermometry during hyperthermia treatment
Trial: 31335198
Drug: Patient-led titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-led titration of insulin glargine 100 U/mL
Trial: 31335198
Drug: Physician-led titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physician-led titration of insulin glargine 100 U/mL
Trial: 28538261
Drug: Better Exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Better Exercise Adherence after Treatment for Cancer (BEAT Cancer)
Trial: 26541350
Drug: Steroid group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid group (0.5 mg/kg intravenous methylprednisolone for 2 days followed by 12 mg daily oral methylprednisolone for 4 days)
Trial: 26541350
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no steroid therapy)
Trial: 17109580
Drug: Probiotic capsules
RxNorm normalized name: Quad-Probiotic Capsules
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsules containing Lactobacillus acidophilus and Bifidobacterium longum
Trial: 10939775
Drug: Homeopathic or
RxNorm normalized name: Drainage Homeopathic Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic or conventional treatment according to patient preference
Trial: 8622602
Drug: Acipimox (ACX)
RxNorm normalized name: acipimox
DrugBank: Acipimox (DB09055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox (ACX) 500 mg (one dose)
Trial: 8622602
Drug: One-dose ACX
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One-dose ACX (500 mg)
Trial: 1533478
Drug: Plasma-derived vaccine
RxNorm normalized name: Haptoglobulin 1/1 (Plasma Derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma-derived vaccine (Green Cross HB-vaccine)
Trial: 1533478
Drug: Yeast-derived recombinant
RxNorm normalized name: YEAST CELL,LIVE DERIVATIVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yeast-derived recombinant vaccine (Engerix B)
Trial: 1533478
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of plasma-derived and yeast-derived vaccines
Trial: 24402597
Drug: Patch
RxNorm normalized name: Patch
DrugBank: Lavender oil (DB14566)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch
Trial: 28366818
Drug: Adjunctive photodynamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive photodynamic therapy (PDT) with scaling and root debridement
Trial: 23767916
Drug: 800 IU
RxNorm normalized name: Vitamin E 800 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 IU of vitamin D3 per day (low dose)
Trial: 23767916
Drug: 4,370 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4,370 IU of vitamin D3 per day (high dose)
Trial: 21204680
Drug: CAD+G (computer-assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAD+G (computer-assisted dieting plus self-management training)
Trial: 19681255
Drug: 19% sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 19% sodium percarbonate brush-applied gel (Crest Night Effects)
Trial: 19681255
Drug: Placebo brush-applied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo brush-applied gel without peroxide
Trial: 15186865
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group of 241 insulin-treated patients
Trial: 26308684
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with 10 mg of ambrisentan plus 40 mg of tadalafil
Trial: 26308684
Drug: Ambrisentan monotherapy
RxNorm normalized name: Ambrisentan
DrugBank: Ambrisentan (DB06403)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ambrisentan monotherapy (10 mg)
Trial: 26308684
Drug: Tadalafil monotherapy
RxNorm normalized name: Tadalafil
DrugBank: Tadalafil (DB00820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tadalafil monotherapy (40 mg)
Trial: 23038021
Drug: Powdered black
RxNorm normalized name: acid black 52
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powdered black tea solids containing 429 mg of polyphenols
Trial: 22045080
Drug: Low-dose adenosine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose adenosine (24 mg)
Trial: 22045080
Drug: High-dose adenosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose adenosine (36 mg)
Trial: 15569335
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (2 g/day)
Trial: 9306037
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g of oral glucose
Trial: 9306037
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of intravenous glucagon
Trial: 9306037
Drug: Insulin treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin treatment for 10-14 days in 15 poorly controlled NIDDM patients
Trial: 8371179
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IA and BF/SM
Trial: 24719474
Drug: Ad5HVR48.EnvA.01 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ad5HVR48.EnvA.01 vaccine (10^9 to 10^11 viral particles)
Trial: 18754438
Drug: Ropivacaine 1.00
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 1.00 mg/kg (0.15%-0.20%)
Trial: 18754438
Drug: Ropivacaine 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 1.25 mg/kg (0.20%-0.25%)
Trial: 18754438
Drug: Ropivacaine 1.50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 1.50 mg/kg (0.30%-0.35%)
Trial: 18754438
Drug: Ropivacaine 2.00
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 2.00 mg/kg (0.30%-0.35%)
Trial: 12592683
Drug: Conventional western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional western therapy (CWT)
Trial: 10379638
Drug: Clozapine 12.5
RxNorm normalized name: clozapine 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine 12.5 mg alone
Trial: 10379638
Drug: Clozapine 12.5
RxNorm normalized name: clozapine 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine 12.5 mg with erythromycin 1500 mg
Trial: 1870835
Drug: Doxium (calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxium (calcium dobesilate) 500 mg, 3 capsules daily for 6 months
Trial: 1870835
Drug: Placebo, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, 3 capsules daily for 6 months
Trial: 6362340
Drug: Oral digoxin
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral digoxin
Trial: 31269891
Drug: Micronized palmitoylethanolamide
RxNorm normalized name: Palmitoylethanolamide
DrugBank: Palmidrol (DB14043)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized palmitoylethanolamide 600 mg/die
Trial: 25827448
Drug: Terminalia arjuna
RxNorm normalized name: terminalia arjuna
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terminalia arjuna (500 mg twice a day)
Trial: 23063141
Drug: Beta-blocker therapy
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker therapy (continued without modification)
Trial: 21564523
Drug: Sotrastaurin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotrastaurin (300 mg b.i.d.)
Trial: 16849748
Drug: rIFL (reduced-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rIFL (reduced-dose bolus fluorouracil plus leucovorin and irinotecan)
Trial: 12170038
Drug: Rescue dextropropoxyphene
RxNorm normalized name: dextropropoxyphene
DrugBank: Dextropropoxyphene (DB00647)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rescue dextropropoxyphene tablets
Trial: 10446825
Drug: TNF-alpha (1.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TNF-alpha (1.25, 12.5, 125, or 250 pg/mL for 20 mins)
Trial: 10446825
Drug: IL-1beta (6.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-1beta (6.25, 12.5, 50, or 200 pg/mL for 20 mins)
Trial: 10446825
Drug: TNF-alpha (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TNF-alpha (1.25 pg/mL) plus IL-1beta (6.25 pg/mL)
Trial: 10446825
Drug: Ceramidase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceramidase inhibitor N-oleoyl ethanolamine (1 microM) or NO synthase inhibitor N(G)-monomethyl-L-arginine (10 microM)
Trial: 313765
Drug: Group 2
RxNorm normalized name: Chlamydophila psittaci biogroup 2 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2 (n = 120) received a bolus of hypertonic glucose, insulin, and potassium in the pump perfusate before aortic cross‐clamping.
Trial: 313765
Drug: Group 3
RxNorm normalized name: Chlamydophila psittaci biogroup 3 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 3 (n = 114) had the aortic root continuously infused with glucose, insulin, and potassium solution at 4 degrees C during aortic cross‐clamping.
Trial: 313765
Drug: Control Group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control Group 1 (n = 157) received no additional glucose, insulin, and potassium solutions.
Trial: 29386049
Drug: Intrathecal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal administration of autologous bone marrow mononuclear cells and standard neurorehabilitation
Trial: 24574125
Drug: Budesonide (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (0.25 mg)
Trial: 22356215
Drug: Controlled-release (CR)
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release (CR) orally disintegrating tablets (ODT) and CR capsules (50 mg)
Trial: 22356215
Drug: Immediate-release (IR)
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release (IR) syrup (reference)
Trial: 21044101
Drug: n-3 supplement
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 supplement (TheraTears Nutrition®)
Trial: 17568957
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group using handheld computers for daily surveys
Trial: 15930540
Drug: Low-dose shock
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose shock wave therapy without anesthetic
Trial: 15930540
Drug: Crossover patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crossover patients receiving active treatment after placebo
Trial: 11845223
Drug: Prednisolone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (30 mg/day for 6 days)
Trial: 10417465
Drug: Group 1:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1: Ophthalmic drape A
Trial: 10417465
Drug: Group 2:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2: Ophthalmic drape B
Trial: 10417465
Drug: Group 3:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 3: Ophthalmic drape C
Trial: 2205624
Drug: Continuous combined
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous combined estrogen/progestogen therapy (2 mg estradiol + 1 mg norethisterone acetate + 500 mg calcium daily)
Trial: 2205624
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + 500 mg calcium daily
Trial: 6992626
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg oral terbutaline
Trial: 6992626
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg terbutaline t.i.d. for a week
Trial: 24386900
Drug: Twice-weekly, physiotherapist-led
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly, physiotherapist-led exercise classes
Trial: 21593280
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ilaprazole once daily for 7 days
Trial: 19942720
Drug: Intramuscular electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular electrical stimulation at latent MTrPs
Trial: 9797593
Drug: EMG biofeedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMG biofeedback training and conventional medical treatment (BFT)
Trial: 9797593
Drug: Conventional medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medical treatment alone (Control)
Trial: 2694330
Drug: Pirenzepine treatment
RxNorm normalized name: pirenzepine
DrugBank: Pirenzepine (DB00670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine treatment for 4 weeks
Trial: 31968301
Drug: Within-treatment frequency
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Within-treatment frequency of use
Trial: 31968301
Drug: Within-treatment abstinence
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Within-treatment abstinence
Trial: 30575054
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic (Group A)
Trial: 30575054
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) antibiotic for 1 day (Group B)
Trial: 30575054
Drug: 1 day
RxNorm normalized name: ZonaCort 11 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 day IV plus 7 days oral antibiotic (Group C)
Trial: 28421639
Drug: cilostazol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilostazol (50 mg twice a day)
Trial: 26537207
Drug: Secondary sentinel
RxNorm normalized name: Sentinel Spectrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secondary sentinel lymph node (SSLN) tracing technique with Methylthioninium chloride injection in group A (138 patients)
Trial: 23789213
Drug: Dingqi analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dingqi analgesic patch
Trial: 23789213
Drug: Sham patch
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham patch (Control)
Trial: 11097156
Drug: Antisense oligodeoxynucleotides
RxNorm normalized name: Exon 53 specific antisense morpholino oligonucleotide
DrugBank: Viltolarsen (DB15005)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Antisense oligodeoxynucleotides at 200, 400, and 800 micromol/L
Trial: 11097156
Drug: Sense oligodeoxynucleotides
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sense oligodeoxynucleotides at 100, 200, 400, and 800 micromol/L
Trial: 1352049
Drug: Concurrent mental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent mental state abnormalities
Trial: 26678391
Drug: Inert control
RxNorm normalized name: inert ingredients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inert control pill
Trial: 23240877
Drug: Nd:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nd:YAG laser irradiation at 1W (group G)
Trial: 21501001
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate
Trial: 19673711
Drug: Heparin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin plus GPI
Trial: 14675269
Drug: Omeprazole treatment
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole treatment for 4 weeks
Trial: 3170995
Drug: Immunotherapy (IT)
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy (IT) with birch extract
Trial: 27697671
Drug: Supportive-therapy control
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive-therapy control
Trial: 16019088
Drug: GTN protocol
RxNorm normalized name: GTN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTN protocol (70 degree tilt, 35 min, CSM at 5 min, 400 microg of glyceryl trinitrate spray administered sublingually at 20 min)
Trial: 16019088
Drug: Drug-free protocol
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-free protocol (70 degree tilt, 45 min, CSM at 5 and 45 min)
Trial: 10566612
Drug: Single agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single agents (platinum analog or vinorelbine)
Trial: 8807070
Drug: Trovafloxacin 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin 50 mg
Trial: 9758289
Drug: Trovafloxacin 100
RxNorm normalized name: trovafloxacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin 100 mg
Trial: 8522468
Drug: Trovafloxacin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin (all doses)
Trial: 1391670
Drug: Piracetam (4,800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piracetam (4,800 mg/d for three months)
Trial: 20493532
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation with imipramine treatment
Trial: 20493532
Drug: Placebo supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo supplementation with imipramine treatment
Trial: 20493532
Drug: Imipramine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine treatment (with or without zinc supplementation)
Trial: 20493532
Drug: Imipramine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine treatment (with zinc supplementation)
Trial: 12236844
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg moxonidine alone
Trial: 12236844
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg quinidine sulphate with 0.2 mg moxonidine
Trial: 10416909
Drug: Passing a
RxNorm normalized name: factor VIII inhibitor bypassing activity
DrugBank: Anti-inhibitor coagulant complex (DB13151)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Passing a daily screen of weaning parameters
Trial: 9419612
Drug: 40 ml
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 ml iohexol
Trial: 9419612
Drug: 40 ml
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 ml ioxaglate
Trial: 29471381
Drug: Prior failure
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior failure of antibiotic therapy
Trial: 26983548
Drug: Memantine (5-15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine (5-15 mg/day)
Trial: 25248944
Drug: Nurse-led titration
RxNorm normalized name: PAD,NURSING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-led titration (NLT) clinic
Trial: 18036357
Drug: Modified glucose-insulin-potassium
RxNorm normalized name: glucose / potassium chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified glucose-insulin-potassium (GIK) regimen (insulin 2.5 U/hour, dextrose and potassium titrated to prevent hyperglycemia)
Trial: 18036357
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution and potassium (controls)
Trial: 18036357
Drug: Modified glucose-insulin-potassium
RxNorm normalized name: glucose / potassium chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified glucose-insulin-potassium (GIK) regimen
Trial: 11898063
Drug: 10 mg/d
RxNorm normalized name: Arixtra 10 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/d of alendronate for 10 weeks (A)
Trial: 11898063
Drug: 20 mg/d
RxNorm normalized name: Valtoco, 20 mg/dose nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/d of alendronate for 5 weeks (B)
Trial: 1322780
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (C)
Trial: 7485937
Drug: Midwife-Administered Intermittent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midwife-Administered Intermittent Bolus (IB) Epidural Analgesia
Trial: 2097716
Drug: Gentamicin or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin or netilmicin given by once daily or thrice daily injections
Trial: 2097716
Drug: Conventional monitoring
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional monitoring of aminoglycoside treatment
Trial: 23452521
Drug: 10-second methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-second methylprednisolone injection
Trial: 23452521
Drug: 30-second methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 30-second methylprednisolone injection